Stockreport

NewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results

NewAmsterdam Pharma Company N.V. - Ordinary Shares  (NAMS) 
PDF –European marketing authorization application on track in 2H25 –  – PREVAIL Phase 3 CVOT remains on track – – Late Breaking BROADWAY and TANDEM data presented at [Read more]